tiprankstipranks
Amicus Therapeutics (FOLD)
NASDAQ:FOLD

Amicus (FOLD) Financial Statements

898 Followers

Amicus Financial Overview

Amicus's market cap is currently ―. The company's EPS TTM is $-0.495; its P/E ratio is -19.77; Amicus is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 110.40M$ 115.08M$ 103.50M$ 94.50M$ 86.27M
Gross Profit$ 96.84M$ 103.76M$ 93.56M$ 85.39M$ 79.33M
EBIT$ -31.15M$ -6.50M$ 551.00K$ -16.24M$ -52.60M
EBITDA$ -28.46M$ -3.78M$ 3.50M$ -13.34M$ -50.68M
Net Income Common Stockholders$ -48.42M$ -33.84M$ -21.58M$ -43.23M$ 194.88M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 239.60M$ 286.20M$ 280.30M$ 265.63M$ 267.11M
Total Assets$ 721.79M$ 777.88M$ 764.08M$ 730.09M$ 700.52M
Total Debt$ 444.49M$ 445.06M$ 454.29M$ 452.17M$ 452.01M
Net Debt$ 204.89M$ 158.86M$ 173.99M$ 186.54M$ 184.90M
Total Liabilities$ 591.10M$ 617.71M$ 630.85M$ 618.51M$ 597.95M
Stockholders Equity$ 130.69M$ 160.17M$ 133.24M$ 111.58M$ 102.57M
Cash Flow-
Free Cash Flow$ -31.51M$ 1.73M$ -39.32M$ -18.67M$ -20.26M
Operating Cash Flow$ -29.70M$ 3.46M$ -37.76M$ -16.47M$ -18.32M
Investing Cash Flow$ 7.54M$ -23.96M$ 35.18M$ 50.34M$ 36.51M
Financing Cash Flow$ -13.31M$ 8.21M$ 37.62M$ 23.67M$ -7.83M
Currency in USD

Amicus Earnings and Revenue History

Amicus Debt to Assets

Amicus Cash Flow

Amicus Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis